Literature DB >> 28196863

Conformational changes in the activation loop of mitochondrial glutaminase C: A direct fluorescence readout that distinguishes the binding of allosteric inhibitors from activators.

Clint A Stalnecker1, Jon W Erickson1, Richard A Cerione2,3.   

Abstract

The first step in glutamine catabolism is catalysis by the mitochondrial enzyme glutaminase, with a specific isoform, glutaminase C (GAC), being highly expressed in cancer cells. GAC activation requires the formation of homotetramers, promoted by anionic allosteric activators such as inorganic phosphate. This leads to the proper orientation of a flexible loop proximal to the dimer-dimer interface that is essential for catalysis (i.e. the "activation loop"). A major class of allosteric inhibitors of GAC, with the prototype being bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) and the related molecule CB-839, binds to the activation loop and induces the formation of an inactive tetramer (two inhibitors bound per active tetramer). Here we describe a direct readout for monitoring the dynamics of the activation loop of GAC in response to these allosteric inhibitors, as well as allosteric activators, through the substitution of phenylalanine at position 327 with tryptophan (F327W). The tryptophan fluorescence of the GAC(F327W) mutant undergoes a marked quenching upon the binding of BPTES or CB-839, yielding titration profiles that make it possible to measure the binding affinities of these inhibitors for the enzyme. Allosteric activators like phosphate induce the opposite effect (i.e. fluorescence enhancement). These results describe direct readouts for the binding of the BPTES class of allosteric inhibitors as well as for inorganic phosphate and related activators of GAC, which should facilitate screening for additional modulators of this important metabolic enzyme.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  fluorescence; glutaminase; glutamine; metabolism; tryptophan

Mesh:

Substances:

Year:  2017        PMID: 28196863      PMCID: PMC5391743          DOI: 10.1074/jbc.M116.758219

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Postembedding immunogold labelling reveals subcellular localization and pathway-specific enrichment of phosphate activated glutaminase in rat cerebellum.

Authors:  J H Laake; Y Takumi; J Eidet; I A Torgner; B Roberg; E Kvamme; O P Ottersen
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

2.  BPTES inhibition of hGA(124-551), a truncated form of human kidney-type glutaminase.

Authors:  Erik W Hartwick; Norman P Curthoys
Journal:  J Enzyme Inhib Med Chem       Date:  2011-10-15       Impact factor: 5.051

3.  Regulation of renal ammoniagenesis. Purification and characterization of phosphate-dependent glutaminase from rat kidney.

Authors: 
Journal:  Arch Biochem Biophys       Date:  1976-05       Impact factor: 4.013

4.  Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth.

Authors:  Ramon C Sun; Nicholas C Denko
Journal:  Cell Metab       Date:  2014-02-04       Impact factor: 27.287

5.  Design and evaluation of novel glutaminase inhibitors.

Authors:  Lee A McDermott; Prema Iyer; Larry Vernetti; Shawn Rimer; Jingran Sun; Melissa Boby; Tianyi Yang; Michael Fioravanti; Jason O'Neill; Liwei Wang; Dylan Drakes; William Katt; Qingqiu Huang; Richard Cerione
Journal:  Bioorg Med Chem       Date:  2016-03-07       Impact factor: 3.641

6.  Full-length human glutaminase in complex with an allosteric inhibitor.

Authors:  Byron DeLaBarre; Stefan Gross; Cheng Fang; Yi Gao; Abhishek Jha; Fan Jiang; Juanhua Song J; Wentao Wei; Jonathan B Hurov
Journal:  Biochemistry       Date:  2011-11-18       Impact factor: 3.162

7.  Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism.

Authors:  Alexandre Cassago; Amanda P S Ferreira; Igor M Ferreira; Camila Fornezari; Emerson R M Gomes; Kai Su Greene; Humberto M Pereira; Richard C Garratt; Sandra M G Dias; Andre L B Ambrosio
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-06       Impact factor: 11.205

8.  Effect of lysine to alanine mutations on the phosphate activation and BPTES inhibition of glutaminase.

Authors:  Charles J McDonald; Eric Acheff; Ryan Kennedy; Lynn Taylor; Norman P Curthoys
Journal:  Neurochem Int       Date:  2014-12-12       Impact factor: 3.921

9.  Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.

Authors:  Matt I Gross; Susan D Demo; Jennifer B Dennison; Lijing Chen; Tania Chernov-Rogan; Bindu Goyal; Julie R Janes; Guy J Laidig; Evan R Lewis; Jim Li; Andrew L Mackinnon; Francesco Parlati; Mirna L M Rodriguez; Peter J Shwonek; Eric B Sjogren; Timothy F Stanton; Taotao Wang; Jinfu Yang; Frances Zhao; Mark K Bennett
Journal:  Mol Cancer Ther       Date:  2014-02-12       Impact factor: 6.261

Review 10.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.

Authors:  R J DeBerardinis; T Cheng
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

View more
  6 in total

1.  Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism.

Authors:  Qingqiu Huang; Clint Stalnecker; Chengliang Zhang; Lee A McDermott; Prema Iyer; Jason O'Neill; Shawn Reimer; Richard A Cerione; William P Katt
Journal:  J Biol Chem       Date:  2018-01-09       Impact factor: 5.157

2.  The activation loop and substrate-binding cleft of glutaminase C are allosterically coupled.

Authors:  Yunxing Li; Sekar Ramachandran; Thuy-Tien T Nguyen; Clint A Stalnecker; Richard A Cerione; Jon W Erickson
Journal:  J Biol Chem       Date:  2019-12-23       Impact factor: 5.157

3.  Evaluation of Microglia/Macrophage Cells from Rat Striatum and Prefrontal Cortex Reveals Differential Expression of Inflammatory-Related mRNA after Methamphetamine.

Authors:  Joanne S Kays; Bryan K Yamamoto
Journal:  Brain Sci       Date:  2019-11-25

Review 4.  Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management.

Authors:  Ping Jin; Jingwen Jiang; Li Zhou; Zhao Huang; Edouard C Nice; Canhua Huang; Li Fu
Journal:  J Hematol Oncol       Date:  2022-07-18       Impact factor: 23.168

Review 5.  Recent Progress in the Discovery of Allosteric Inhibitors of Kidney-Type Glutaminase.

Authors:  Sarah C Zimmermann; Bridget Duvall; Takashi Tsukamoto
Journal:  J Med Chem       Date:  2018-07-03       Impact factor: 8.039

6.  Identification and characterization of a novel glutaminase inhibitor.

Authors:  Henning Cederkvist; Shrikant S Kolan; Jonas Aakre Wik; Zeynep Sener; Bjørn Steen Skålhegg
Journal:  FEBS Open Bio       Date:  2021-11-08       Impact factor: 2.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.